Key statistics dashboard for Niagen Bioscience Inc (NAGE). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredi...
Stock Data
| Price | $3.00 |
| Market Cap | $239M |
| Enterprise Value | $174.5M |
| Beta | 2.23 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 15.45 |
| Price / Book | 2.88 |
| P/S | 1.85 |
| EV/EBITDA | 9.44 |
| EV/Sales | 1.35 |
| EV/FCF | 30.76 |
| P/FCF | 42.11 |
| Earnings Yield | 6.72% |
| FCF Yield | 2.37% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 64.24% |
| EBIT Margin | 12.91% |
| EBITDA Margin | 14.32% |
| Operating Margin | 6.67% |
| Net Margin | 12.39% |
| Return on Equity | 20.50% |
| Return on Assets | 15.00% |
| Return on Invested Capital | 8.75% |
| Return on Capital Employed | 9.41% |
Financial Health
| Current Ratio | 6.50 |
| Quick Ratio | 5.13 |
| Cash Ratio | 4.43 |
| Debt / Equity | 0.03 |
| Debt / Assets | 2.19% |
| Net Debt / EBITDA | -3.49 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 10.48 |
Per-Share Data
| Revenue per share | 1.63 |
| Book Value per share | 1.04 |
| Cash per share | 0.84 |
| FCF per share | 0.07 |
| Tangible Book Value per share | 0.97 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 5 |
| Avg rating (1-5) | 1.00 |
Related companies: AKBA · CRVS · KALV · KROS · OLMA · PRTA · RGNX
Explore sector: Healthcare · Biotechnology
More sections of NAGE: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks